Zika surprise—African strain can do more damage than Asian strain

November 9, 2017 by John Hobbs, University of Southern California
A digitally colorized view of the Zika virus, which causes microcephaly in babies. Credit: Cynthia Goldsmith, Center for Disease Control

The Zika virus has spread to 44 countries, with thousands infected and thousands of babies born with microcephaly, a rare complication that causes small heads.

Although research dollars are being poured into understanding the , there are still numerous questions.

At USC, Assistant Professor Jianfu Chen is working to answer some of those persistent queries. His lab at USC's Center for Craniofacial Molecular Biology studies the genetic mutations that cause .

"There are some genetic deletions in the human population that can cause microcephaly, and we are trying to understand the cause of the defect," said Chen, a researcher at the Herman Ostrow School of Dentistry of USC.

Although microcephaly can occur naturally, Zika can also cause it—though the process how isn't entirely known.

Zika's origins

The origins of Zika can be divided into two lineages: Asian and African. The strain that has caused outbreaks—and born with microcephaly—in South America and the Caribbean come from the Asian strain of the disease.

There have been no reports of the African origin Zika causing microcephaly, and that was a puzzle, Chen said. The strains are relatively similar, with a difference of only about 110 amino acid bases.

Researchers wanted to know why the strains have different impacts on brain development by doing a side-by-side comparison using the animal model developed from previous studies, he said.

In the new study, Chen injected embryonic mouse brains with Asian and African of Zika. Surprisingly, he found that the African Zika virus caused more brain damage and was more likely to kill the baby mice than the Asian strain of the virus. It increased cell death in neuron precursors and neurons, creating smaller, more damaged brains.

The study also found that the dengue virus, a close family member of the Zika virus, also caused smaller size, but that the damage was much less than with Zika.

The results of Chen's study were published in the journal Development.

No direct documention

So far, there hasn't been direct documentation of the African strain causing babies to be born with microcephaly, and that could because the is so severe that the baby doesn't survive pregnancy or early abortion, Chen said.

Another possibility is that in the regions where the African strain exists, women have immunity to the infection before they get pregnant, so the virus doesn't cause that much damage to the baby.

A third possibility is that babies are being born with microcephaly, but that the medical recording systems in the countries where it's happening aren't recording or documenting those events.

"We just don't know," said Chen, who hopes to find out more of Zika's secrets in the future.

Explore further: Brazil to monitor Zika babies for three years

Related Stories

Brazil to monitor Zika babies for three years

November 18, 2016
Brazil's Health Ministry said Friday that babies whose mothers were infected by the Zika virus during pregnancy will be monitored until they are 3 years old to detect the presence of possible problems other than microcephaly.

Mouse model reveals extensive postnatal brain damage caused by Zika infection

November 22, 2016
A team of scientists led by researchers at the University of Georgia has developed a new mouse model that closely mimics fetal brain abnormalities caused by the Zika virus in humans.

Paraguay reports first two cases of Zika birth defect

July 27, 2016
Paraguay reported its first two cases Wednesday of babies born with microcephaly linked to the Zika virus, which is blamed for a surge in the birth defect across Latin America.

Brazil finds Zika in microcephaly babies' brains

February 15, 2016
Brazilian researchers said Monday that the discovery of Zika in the brains of babies with microcephaly adds to growing evidence of a link between the mosquito-transmitted virus and the birth defect.

Panama finds first case of microcephaly tied to Zika

March 19, 2016
Doctors in Panama have identified a baby born with a rare brain disorder thought to be linked to Zika, the first such case outside Brazil.

Panama reports 4 cases of Zika-related microcephaly

May 5, 2016
Health authorities in Panama said Thursday that they have identified four cases of the birth defect microcephaly linked to the Zika virus.

Recommended for you

Researchers define possible molecular pathway for neurodegeneration in prion diseases

September 21, 2018
A new study has shed light on the mechanisms underlying the progression of prion diseases and identified a potential target for treatment.

A new approach to developing a vaccine against vivax malaria

September 21, 2018
A novel study reports an innovative approach for developing a vaccine against Plasmodium vivax, the most prevalent human malaria parasite outside sub-Saharan Africa. The study led by Hernando A. del Portillo and Carmen Fernandez-Becerra, ...

Pre-clinical success for a universal flu vaccine offers hope for third generation approach

September 21, 2018
Researchers from the University of Oxford's Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine in a new paper published in Nature Communications.

Fighting a deadly parasite: Scientists devise a method to store Cryptosporidium, aiding vaccine research efforts

September 21, 2018
In May, just before one of the hottest summers on record, the U.S. Centers for Disease Control and Prevention issued a warning about diseases lurking in recreational water facilities like swimming pools and water playgrounds. ...

Scientists make significant discovery in the fight against drug-resistant tuberculosis

September 20, 2018
A team of scientists have identified a naturally occurring antibiotic that may help in the fight against drug-resistant Tuberculosis.

Anti-cancer drugs may hold key to overcoming antimalarial drug resistance

September 20, 2018
Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.